Akums Drugs and Pharmaceuticals Limited — Others, 28-12-2024: Trading Window

Akums has announced the closure of the trading window for its securities, effective from January 1, 2025, until 48 hours post the declaration of the financial results for the quarter and half-year ending December 31, 2024. The precise date for the board meeting to approve these results will be communicated later. This move aligns with compliance requirements regarding insider trading, signaling the company's commitment to governance and transparency. Investors should note this could lead to a cautious sentiment ahead of upcoming results, as typical trading activity will be restricted.